_version_ 1782434406073368576
author Shim, Joon Ho
Oh, Seung Hwan
Jun, Ji-Young
Kim, Jun-Hwan
Park, Hae-Young
Park, Ji-Hye
Lee, Dong-Youn
author_facet Shim, Joon Ho
Oh, Seung Hwan
Jun, Ji-Young
Kim, Jun-Hwan
Park, Hae-Young
Park, Ji-Hye
Lee, Dong-Youn
author_sort Shim, Joon Ho
collection PubMed
description
format Online
Article
Text
id pubmed-4884729
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-48847292016-06-03 Exacerbation of Psoriasis after Imatinib Mesylate Treatment Shim, Joon Ho Oh, Seung Hwan Jun, Ji-Young Kim, Jun-Hwan Park, Hae-Young Park, Ji-Hye Lee, Dong-Youn Ann Dermatol Letter to the Editor Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016-06 2016-05-25 /pmc/articles/PMC4884729/ /pubmed/27274651 http://dx.doi.org/10.5021/ad.2016.28.3.409 Text en Copyright © 2016 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Shim, Joon Ho
Oh, Seung Hwan
Jun, Ji-Young
Kim, Jun-Hwan
Park, Hae-Young
Park, Ji-Hye
Lee, Dong-Youn
Exacerbation of Psoriasis after Imatinib Mesylate Treatment
title Exacerbation of Psoriasis after Imatinib Mesylate Treatment
title_full Exacerbation of Psoriasis after Imatinib Mesylate Treatment
title_fullStr Exacerbation of Psoriasis after Imatinib Mesylate Treatment
title_full_unstemmed Exacerbation of Psoriasis after Imatinib Mesylate Treatment
title_short Exacerbation of Psoriasis after Imatinib Mesylate Treatment
title_sort exacerbation of psoriasis after imatinib mesylate treatment
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884729/
https://www.ncbi.nlm.nih.gov/pubmed/27274651
http://dx.doi.org/10.5021/ad.2016.28.3.409
work_keys_str_mv AT shimjoonho exacerbationofpsoriasisafterimatinibmesylatetreatment
AT ohseunghwan exacerbationofpsoriasisafterimatinibmesylatetreatment
AT junjiyoung exacerbationofpsoriasisafterimatinibmesylatetreatment
AT kimjunhwan exacerbationofpsoriasisafterimatinibmesylatetreatment
AT parkhaeyoung exacerbationofpsoriasisafterimatinibmesylatetreatment
AT parkjihye exacerbationofpsoriasisafterimatinibmesylatetreatment
AT leedongyoun exacerbationofpsoriasisafterimatinibmesylatetreatment